Brind.

Rating changes were reported for several companies on August 8, 2026, including upgrades from hold to buy and sell to hold.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Acadia Pharmaceuticals Applied Optoelectronics Amgen

Keep exploring

The entities involved

Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

Nothing else this week.
Applied Optoelectronics
company in Sugar Land, United States

Nothing else this week.
Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05

Related events

Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.Sep 12

Coverage

Newest first; wire copies grouped

Aug 8themarketsdaily.com